No abstract

Objective To analyse preterm birth rates worldwide to assess the incidence of this public health problem, map the regional distribution of preterm births and gain insight into existing assessment strategies. Methods Data on preterm birth rates worldwide were extracted during a previous systematic review of published and unpublished data on maternal mortality and morbidity reported between 1997 and 2002. Those data were supplemented through a complementary search covering the period 2003-2007. Region-specific multiple regression models were used to estimate the preterm birth rates for countries with no data. Findings We estimated that in 2005, 12.9 million births, or 9.6% of all births worldwide, were preterm. Approximately 11 million (85%) of these preterm births were concentrated in Africa and Asia, while about 0.5 million occurred in each of Europe and North America (excluding Mexico) and 0.9 million in Latin America and the Caribbean. The highest rates of preterm birth were in Africa and North America (11.9% and 10.6% of all births, respectively), and the lowest were in Europe (6.2%). Conclusion Preterm birth is an important perinatal health problem across the globe. Developing countries, especially those in Africa and southern Asia, incur the highest burden in terms of absolute numbers, although a high rate is also observed in North America. A better understanding of the causes of preterm birth and improved estimates of the incidence of preterm birth at the country level are needed to improve access to effective obstetric and neonatal care.Une traduction en français de ce résumé figure à la fin de l'article. Al final del artículo se facilita una traducción al español. ‫املقالة.‬ ‫لهذه‬ ‫الكامل‬ ‫النص‬ ‫نهاية‬ ‫يف‬ ‫الخالصة‬ ‫لهذه‬ ‫العربية‬ ‫الرتجمة‬

No abstract

No abstract

Androstenedione and oestradiol were measured by radioimmunoassay in the utero-ovarian venous plasma of two ewes during anoestrus. The concentrations of both steroids were significantly higher than the corresponding concentrations in peripheral plasma, indicating that androstenedione and oestradiol are secreted by the ovary during anoestrus. The concentration of LH during anoestrus was measured by radioimmunoassay in jugular venous plasma of control ewes, ewes immunized against 11alpha-OH-androstenedione-bovine serum albumin and ewes that had been ovariectomized and hystrectomized 9 months previously. During a 12 h sampling period, discharges of LH occurred more frequently in the immunized ewes than in the control group but less frequently than in the ovariectomized group. The frequency of discharge was positively correlated with the titre of androstenedione antibodies in the immunized animals. After injection of 25 mug oestradiol benzoate (OB) all controls, 3 out of 5 immunized and 4 out of 5 ovariectomized-hysterectomized ewes showed positive feedback. No positive feedback occurred in the two ewes with the highest antibody titres to androstenedione, but negative feedback in response of OB apperaed to function normally in all the androstenedione immunized sheep. It is postulated that androstenedione, or one of its metabolites, normally modulates the effects of oestradiol in the control of gonadotrophin secretion in the ewe.